Help oversee talent in skills competition
Sign up to be a workshop supervisor at WorldSkills London 2011
Bringing together 1,000 young people from across the globe, the event see will the youngsters compete for medals in 45 categories across six sectors, including manufacturing (and engineering) technology, construction and building technology and transportation and logistics.
WorldSkills London 2011 takes place from 5-8 October at ExCeL London and manufacturing professionals are needed to help as workshop supervisors, who will be responsible for the preparation of materials, health and safety, security and workshop upkeep. They will also support the international judging panel as they test the competitors.
Signing up for the job requires a commitment of approximately one day per month for the next year, increasing to two or three days a month in the six months leading up to the competition and full-time for 10-12 days during the competition. Accommodation, expenses and a remuneration package are available to those who sign up.
Executive director of WorldSkills London 2011, Aidan Jones said: ‘Skills shape our world and workshop supervisors will play an essential role in this massive demonstration of the next generation of talent.’
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Finance
Lario Therapeutics secures $2.4m from MJFF and Wellcome to expand CNS calcium channel programmes
The company has been awarded $2.4m in grant funding from The Michael J. Fox Foundation for Parkinson's Research and Wellcome to advance its neuronal calcium channel platform into Parkinson's disease and post-traumatic stress disorder
Research & Development
Horizon Europe 2025 grant backs Phase II trial of HER-096 for Parkinson’s disease
Herantis Pharma has secured selection for €8m in non-dilutive funding under Horizon Europe to advance a Phase II proof-of-concept study of its subcutaneously delivered Parkinson’s therapy candidate HER-096